BVNRY Stock Overview - The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
PNK:BVNRY

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

August 28, 2024

Description

Loading...

Returns 1M 6M 1Y 5Y 10Y
$BVNRY N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A
Valuation P/E Ratio (TTM) P/S Ratio (TTM)
Bavarian Nordic A/S Loading... Loading...
Sector Name Loading... N/A

Related

MLYSMineralys Therapeutics, Inc.0.7%
ANEBAnebulo Pharmaceuticals, Inc.-2.0%
BCABBioAtla, Inc.-2.8%
BCYCBicycle Therapeutics plc-0.3%
ADAGAdagene Inc.-0.4%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue1,217M1,021M1,007M1,370M501M662M1,852M1,898M3,151M7,057M
Growth Rate--16.1%-1.4%36.1%-63.5%32.3%179.6%2.5%66.0%124.0%
EBITDA66M127M113M345M-278M-259M810M125M395M2,051M
EBITDA Margin5.4%12.4%11.2%25.2%-55.5%-39.2%43.7%6.6%12.5%29.1%
Net Income26M59M31M181M-362M-347M278M-465M-347M1,475M
NI Margin2.1%5.8%3.0%13.2%-72.3%-52.3%15.0%-24.5%-11.0%20.9%
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.